Healthcare • Biotechnology
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine
kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Chapel Hill, North Carolina.
Company profile from EODHD, stored Oct 21, 2026.
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Jul 31, 2026 | — | — | — | -$18.8M | -$17.8M |
| Mar 2026filed May 12, 2026 | — | — | — | -$16.6M | -$15.7M |
| Dec 2025filed Mar 10, 2026 | — | — | — | -$16.4M | -$15.5M |
| Sep 2025filed Nov 12, 2025 | — | — | — | -$16.8M | -$15.8M |
| Jun 2025filed Aug 13, 2025 | — | — | — | -$11.8M | -$10.8M |
| Mar 2025filed May 14, 2025 | — | — | — | -$11.3M | -$10.4M |
| Dec 2024filed Mar 25, 2025 | $2.0K | -65.5% | 50.0% | -$7.3M | -$6.3M |
| Sep 2024filed Nov 13, 2024 | — | — | — | $4.6M | -$4.0M |
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Mar 10, 2026 | — | — | — | -$56.4M | -$52.6M |
| Dec 2024filed Mar 25, 2025 | — | — | — | -$19.5M | -$17.6M |
| Dec 2023filed Mar 28, 2024 | — | — | — | -$8.2M | -$7.7M |
| Dec 2022filed Mar 31, 2023 | — | — | — | -$11.1M | -$11.0M |
| Dec 2021filed Mar 29, 2022 | — | — | — | -$32.7M | -$32.5M |
| Dec 2020filed Mar 31, 2021 | — | — | — | -$9.9M | -$9.9M |
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched TENX. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
7,229,252 shares short
+47,126 shares (+0.7%) vs Sep 30, 2026
23.5% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
7,182,126 shares short
+1,678,284 shares (+30.5%) vs Sep 15, 2026
23.3% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
5,503,842 shares short
-3,773,063 shares (-40.7%) vs Aug 31, 2026
Share of float unavailable. Published Sep 24, 2026.
Settlement Aug 31, 2026
9,276,905 shares short
+3,802,922 shares (+69.5%) vs Aug 14, 2026
Share of float unavailable. Published Sep 10, 2026.
Settlement Aug 14, 2026
5,473,983 shares short
+2,917,505 shares (+114.1%) vs Jul 31, 2026
Share of float unavailable. Published Aug 25, 2026.
Settlement Jul 31, 2026
2,556,478 shares short
+509,941 shares (+24.9%) vs Jul 15, 2026
Share of float unavailable. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
See the recorded cash amounts and dates behind TENX’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
No qualified cash-dividend records are stored. This does not establish that the company pays no dividend.
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
1 for 80 · reverse split
Effective Jan 3, 2024
Each 80 pre-split shares become 1 post-split share.
Source: EODHD
1 for 20 · reverse split
Effective Jan 5, 2023
Each 20 pre-split shares become 1 post-split share.
Source: EODHD
1 for 20 · reverse split
Effective Feb 26, 2018
Each 20 pre-split shares become 1 post-split share.
Source: EODHD
1 for 20 · reverse split
Effective May 13, 2013
Each 20 pre-split shares become 1 post-split share.
Source: EODHD
1 for 15 · reverse split
Effective Nov 9, 2009
Each 15 pre-split shares become 1 post-split share.
Source: EODHD
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workSign in to see your position size
We’ll show you if TENX is in your portfolio and how much it contributes.
Sign inLoading market dates
32 smart-money holders: institutions with a high Holder IQ
Smart-money 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bullish
Last trade: buy 17 days ago
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
Stored recent-activity label: bullish. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 2
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
Stored recent-activity label: bullish. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
111 filers reported a long position in TENX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
49%
of the 30.3M shares 13-F filers reported
Moves vs Q1 2026
8 added1 trimmed
1 new
Net shares held
+225.5%
across the 9 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | FMR LLC | $57.4M · 3.9M shares | 3.9M | +1,122.1% |
| 2 | Vivo Capital, LLC | $36.4M · 2.5M shares | 2.5M | +1,100% |
| 3 | BlackRock, Inc. | $25.1M · 1.7M shares | 1.7M | +10,078.4% |
| 4 | PERCEPTIVE ADVISORS LLC | $24.7M · 1.7M shares | 1.7M | +17.4% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | $16.7M · 1.1M shares | 1.1M | +335.5% |
| 6 | MILLENNIUM MANAGEMENT LLC | $12.7M · 876.2K shares | 876.2K | +64.1% |
| 7 | Ikarian Capital, LLC | $11.5M · 787.6K shares | 787.6K | -22.6% |
| 8 | Candriam S.C.A. | $10.9M · 749.6K shares | 749.6K | New |
| 9 | CITADEL ADVISORS LLC | $10.6M · 728.6K shares | 728.6K | +377.7% |
| 10 | RTW INVESTMENTS, LP | $10.1M · 696.6K shares | 696.6K | +88.1% |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign inHolders of more than 5% of TENX file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Oct 27, 2026 | BlackRock, Inc.13G · passive · amended | 7.5% |
| Oct 15, 2026 | MILLENNIUM MANAGEMENT LLC13G · passive · amended | 3.6%under 5% |
| Oct 13, 2026 | SPHERA FUNDS MANAGEMENT LTD.13G · passive · amended | 7.09% |
| Oct 9, 2026 | Dellora Investments LP13G · passive · amended | 6.4% |
| Sep 11, 2026 | ING GROEP NV13G · passive · amended | 0%under 5% |
| Sep 8, 2026 | ADAR1 Capital Management, LLC13G · passive | 14% |
| Sep 8, 2026 | FMR LLC13G · passive · amended | 1.4%under 5% |
| Aug 14, 2026 | RTW INVESTMENTS, LP13G · passive · amended | 9.9% |
| Aug 14, 2026 | Venrock Healthcare Capital Partners III LP13G · passive · amended | 4.7%under 5% |
| Aug 14, 2026 | Vivo Opportunity Fund Holdings LP13G · passive · amended | 9% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.